A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
University College, London
National Cancer Institute (NCI)
Takeda
Fondazione Italiana Linfomi - ETS
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
University of Sydney
UNICANCER
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
University College, London
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Shandong University
Shandong University
Children's Oncology Group
Inovio Pharmaceuticals
Inovio Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)
Fondazione Michelangelo
Children's Oncology Group
M.D. Anderson Cancer Center
University of Cologne
Canadian Cancer Trials Group
University of Cologne
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Lymphoma Study Association
The Lymphoma Academic Research Organisation
Nanfang Hospital, Southern Medical University
Children's Oncology Group
French Innovative Leukemia Organisation
Fondazione Michelangelo
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC